A composition for oral cavity
    11.
    发明公开
    A composition for oral cavity 审中-公开
    Zusammensetzung zur Verwendung in derMundhöhle

    公开(公告)号:EP1400236A1

    公开(公告)日:2004-03-24

    申请号:EP03020539.7

    申请日:2003-09-17

    IPC分类号: A61K7/16

    CPC分类号: A61Q11/00 A61K8/66

    摘要: An object of the present invention is to provide a composition for the oral cavity which protects gingiva and oral mucosas against a bleaching treatment with a tooth bleaching agent. The present invention provides a composition for the oral cavity containing a free radical scavenger.

    摘要翻译: 本发明的目的是提供一种口腔用组合物,其用牙齿漂白剂保护牙龈和口腔粘膜免于漂白处理。 本发明提供了含有自由基清除剂的口腔用组合物。

    TOPICAL ANESTHESIA COMPOSITIONS
    12.
    发明公开
    TOPICAL ANESTHESIA COMPOSITIONS 有权
    局部麻醉组合物

    公开(公告)号:EP1350522A1

    公开(公告)日:2003-10-08

    申请号:EP02729385.1

    申请日:2002-01-10

    摘要: A composition for local anesthesia which comprises a local anesthetic as an active ingredient and an agent for maintaining anesthetic action selected from the group consisting of acidic mucopolysaccharides such as sodium chondroitin sulfate and cellulose derivatives such as hydroxypropylmethylcellulose, and does not contain catecholamines, which has durability of anesthetic action suitable for minor dental operations such as tooth extraction, and can be used as a safe composition for local anesthesia used for oral surgery or dental treatment.

    摘要翻译: 一种局部麻醉用组合物,其特征在于,含有局部麻醉剂作为有效成分,并含有选自硫酸软骨素钠等酸性粘多糖和羟丙基甲基纤维素等纤维素衍生物的麻醉作用维持剂,且不含儿茶酚胺类, 的适用于诸如拔牙等小型牙科手术的麻醉作用,并且可以用作用于口腔外科或牙科治疗的局部麻醉的安全组合物。

    Pharmaceutical composition
    17.
    发明公开
    Pharmaceutical composition 失效
    Pharmazeutische Zusammensetzung。

    公开(公告)号:EP0441333A1

    公开(公告)日:1991-08-14

    申请号:EP91101560.0

    申请日:1991-02-06

    摘要: The present invention relates to a pharmaceutical composition in a form of a film. The composition comprises (a) a butyrophenone compound and (b) a vehicle comprising polyvinyl acetal diethylaminoacet ate and polyvinyl pyrrolidone. The ratio of the compound to the vehicle is from 1% to 80% by weight based on the total weight of the vehicle and the ratio by weight of polyvinyl acetal diethylaminoacetate and polyvinyl pyrrolidone is from 1 : 9 to 9 : 1.
    The pharmaceutical composition can be applied to the skin of a patient for a long time and maintain a therapeutically effective blood level of the butyrophenone.

    摘要翻译: 本发明涉及一种薄膜形式的药物组合物。 组合物包含(a)丁酰苯酚化合物和(b)包含聚乙烯醇缩醛二乙基氨基乙酸酯和聚乙烯吡咯烷酮的载体。 化合物与载体的比率为基于载体的总重量的1重量%至80重量%,聚乙烯醇缩醛二乙基氨基乙酸酯和聚乙烯吡咯烷酮的重量比为1:9至9:1。药物组合物 可以长时间地施用于患者的皮肤,并且维持丁酰丙酮的治疗有效的血液水平。